News
Innovative Medicines based on
ImmunoModulatory Biologics
-
Media Room
-
News
(May 10, 2022) ‘OX40LxTNFα’ bispecific antibody project of IMBiologics funded by KDDF
-
- Date
- 2022-08-30 16:37:33
-
- View
- 1189
For more information, please visit : IMBiologics News (full article available in Korean)
- President(CEO) : Gyongsik Ha
- 260, Changnyong-daero, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea